Absynth Biologics
-
2007
Company Description
Absynth Biologics develops treatments to prevent immunological diseases and therapies to combat bacterial infections.
Absynth Biologics has been created with the initial goal of developing immunological prophylaxis and therapy to combat bacterial infections. Absynth’s strategy is to exploit the characterisation of carefully selected novel proteins Staphylococcus aureus (S. aureus)in bacteria as immunological targets.
-
Manufacturer:
Science and Engineering -
Formed:
2007 -
Founders:
Simon Foster -
Company Website:
-
Company E-mail:
-
Company Address:
The Bioincubator, 40 Leavygreave RoadUnited KingdomSheffield -
CEO:
- Simon Foster
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits